353 related articles for article (PubMed ID: 31820492)
1. Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer.
Wu R; Wang L; Yin R; Hudlikar R; Li S; Kuo HD; Peter R; Sargsyan D; Guo Y; Liu X; Kong AN
Mol Carcinog; 2020 Feb; 59(2):227-236. PubMed ID: 31820492
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Combats against Gastrointestinal Cancer: A Review of Current Knowledge Regarding Epigenetics Mechanisms with a Focus on DNA Methylation.
Jafari-Nozad AM; Jafari A; Zangooie A; Behdadfard M; Zangouei AS; Aschner M; Farkhondeh T; Samarghandian S
Curr Med Chem; 2023; 30(38):4374-4388. PubMed ID: 36644869
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1.
Guo Y; Shu L; Zhang C; Su ZY; Kong AN
Biochem Pharmacol; 2015 Mar; 94(2):69-78. PubMed ID: 25640947
[TBL] [Abstract][Full Text] [Related]
4. DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.
Guo Y; Wu R; Gaspar JM; Sargsyan D; Su ZY; Zhang C; Gao L; Cheng D; Li W; Wang C; Yin R; Fang M; Verzi MP; Hart RP; Kong AN
Carcinogenesis; 2018 May; 39(5):669-680. PubMed ID: 29547900
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers.
Akbari A; Sedaghat M; Heshmati J; Tabaeian SP; Dehghani S; Pizarro AB; Rostami Z; Agah S
Biomed Pharmacother; 2021 Sep; 141():111849. PubMed ID: 34214729
[TBL] [Abstract][Full Text] [Related]
6. Curcumin and colorectal cancer: An update and current perspective on this natural medicine.
Weng W; Goel A
Semin Cancer Biol; 2022 May; 80():73-86. PubMed ID: 32088363
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates.
Hudlikar R; Wang L; Wu R; Li S; Peter R; Shannar A; Chou PJ; Liu X; Liu Z; Kuo HD; Kong AN
Cancer Prev Res (Phila); 2021 Feb; 14(2):151-164. PubMed ID: 33055265
[TBL] [Abstract][Full Text] [Related]
8. Curcumin from Turmeric Rhizome: A Potential Modulator of DNA Methylation Machinery in Breast Cancer Inhibition.
Fabianowska-Majewska K; Kaufman-Szymczyk A; Szymanska-Kolba A; Jakubik J; Majewski G; Lubecka K
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498667
[TBL] [Abstract][Full Text] [Related]
9. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
10. Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism.
Zhang W; Cui N; Ye J; Yang B; Sun Y; Kuang H
Chin Herb Med; 2022 Apr; 14(2):244-253. PubMed ID: 36117672
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and Apoptosis Effects of Curcumin Analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on Human Colon Cancer Cells HT29 and SW620 In Vitro.
Rahim NFC; Hussin Y; Aziz MNM; Mohamad NE; Yeap SK; Masarudin MJ; Abdullah R; Akhtar MN; Alitheen NB
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652694
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of healthy colon establishes aspirin as a suppressor of cancer-related epigenetic aging.
Noreen F; Chaber-Ciopinska A; Regula J; Schär P; Truninger K
Clin Epigenetics; 2020 Nov; 12(1):164. PubMed ID: 33143725
[TBL] [Abstract][Full Text] [Related]
14. Curcuma as an adjuvant in colorectal cancer treatment.
Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
[TBL] [Abstract][Full Text] [Related]
15. Curcumin and cancer: barriers to obtaining a health claim.
Devassy JG; Nwachukwu ID; Jones PJ
Nutr Rev; 2015 Mar; 73(3):155-65. PubMed ID: 26024538
[TBL] [Abstract][Full Text] [Related]
16. Chemical markers' knockout coupled with UHPLC-HRMS-based metabolomics reveals anti-cancer integration effects of the curcuminoids of turmeric (Curcuma longa L.) on lung cancer cell line.
Zhou JL; Zheng JY; Cheng XQ; Xin GZ; Wang SL; Xie T
J Pharm Biomed Anal; 2019 Oct; 175():112738. PubMed ID: 31362249
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.
Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP
Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774
[TBL] [Abstract][Full Text] [Related]
18. Curcumin and Derivatives in Nanoformulations with Therapeutic Potential on Colorectal Cancer.
Idoudi S; Bedhiafi T; Hijji YM; Billa N
AAPS PharmSciTech; 2022 Apr; 23(5):115. PubMed ID: 35441267
[TBL] [Abstract][Full Text] [Related]
19. The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.
Guo Y; Liu Y; Zhang C; Su ZY; Li W; Huang MT; Kong AN
Carcinogenesis; 2016 Jun; 37(6):616-624. PubMed ID: 27207670
[TBL] [Abstract][Full Text] [Related]
20. Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis.
Murakami A; Furukawa I; Miyamoto S; Tanaka T; Ohigashi H
Biofactors; 2013; 39(2):221-32. PubMed ID: 23233214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
